Dec 14, 2023, 07:23 AM by

Analyst firm, Frost & Sullivan today named AppOmni its Company of the Year for global SaaS Security Posture Management (SSPM) industry leadership. According to the report: “While many market participants are enhancing their SSPM solutions by increasing the number of SaaS applications being covered, the market still has an unmet need for an SSPM solution that provides consistent and comprehensive security coverage across core and custom SaaS applications. AppOmni addresses this market demand by offering its one-stop AppOmni Platform, which is the first SSPM solution in the market that enables customers to implement common security capabilities across their entire SaaS ecosystem.”

Dec 14, 2023, 07:23 AM by

Qlucore, a leader in software development for precision cancer diagnostics, has taken a significant and crucial step towards obtaining a CE marked solution, initiating a formal performance evaluation study in Sweden and Denmark. Results from the study are expected early in 2024.

Dec 14, 2023, 07:23 AM by

I wanted to share some exciting insights from a joint report by Ashfield Event Experiences, part of Inizio Engage XD, and the International Pharmaceutical Congress Advisory Association (IPCAA). This report delves into the evolving landscape of healthcare provider (HCP) behaviors and attitudes towards medical congresses and conventions, particularly in the context of the return of in-person events. The full release is below.

Dec 13, 2023, 08:21 AM by

The industry growth include Increased government funding for life science technologies, growth of cell and gene therapies, rise in demand for biopharmaceuticals, technological advancements in life science tools, rise in the number of strategic deals & developments, and applications of genomic and proteomic technologies for precision medicine.

Dec 13, 2023, 08:02 AM by

Dec 13, 2023, 08:02 AM by

Avalon Announces Better Way for Health Insurance Plans to Manage Growth and Costs of Genetic Testing

Dec 13, 2023, 08:02 AM by

ome Biosciences, Inc., the programmable genomic integration company, has launched to usher in a new era of genomic medicines based on programmable genomic integration (PGI). PGI enables the insertion of any DNA sequence, of any size, into any programmed genomic location. The Company has raised $213 million in Series A and B funding from investors: Andreessen Horowitz (a16z) Bio + Health, ARCH Venture Partners, GV, Longwood Fund, Polaris Partners, Bruker Corporation, FUJIFILM Corporation, Alexandria Venture Investments and others.

Dec 13, 2023, 08:02 AM by

AI company transitions app to subscription model and adds exclusive new features for users in the UK, Canada, Europe and global users outside the U.S.

Dec 13, 2023, 01:00 AM by User Not Found

Bio-IT World | The development of antibiotics for treating tuberculosis in the 1940s eventually closed the doors of high-altitude sanitoriums that had long been the best therapeutic option for millions of patients. In much the same way, researchers at the Buck Institute for Research on Aging hope to one day eliminate the need to admit people suffering from Alzheimer’s, Parkinson’s disease, and other age-related phenomena to a geriatric or psychiatric hospital.

Dec 12, 2023, 08:43 AM by

Distributing real-world data to researchers in hours instead of days

Dec 12, 2023, 08:43 AM by

Carterra Inc. and ENPICOM B.V. announced today a collaboration to streamline the analysis of rapidly growing sequencing and antibody screening data generated in the lab.

Dec 12, 2023, 01:00 AM by User Not Found

Bio-IT World | The development of antibiotics for treating tuberculosis in the 1940s eventually closed the doors of high-altitude sanitoriums that had long been the best therapeutic option for millions of patients. In much the same way, researchers at the Buck Institute for Research on Aging hope to one day eliminate the need to admit people suffering from Alzheimer’s, Parkinson’s disease, and other age-related phenomena to a geriatric or psychiatric hospital.

Dec 11, 2023, 08:54 AM by

BugBiome announced as the winner of the Discovery Spark life science business support programme and will be awarded a business support package worth over £100,000, including one year of free lab space at Discovery Park and £50,000 investment from Discovery Park Ventures.

Dec 11, 2023, 08:54 AM by

Dec 8, 2023, 07:44 AM by

Dec 8, 2023, 07:44 AM by

Dec 8, 2023, 01:00 AM by User Not Found

Bio-IT World | For almost two decades, members of the life science community bemoaned something that most outsiders never realized: that the “finished” human genome assembly had never actually been finished. Now, thanks to remarkable efforts from the Telomere-to-Telomere (T2T) consortium, we finally have a complete human reference genome.

Dec 7, 2023, 08:06 AM by

Modernizing the 150-year-old microscope-based practice with digital innovation

Dec 7, 2023, 08:06 AM by

Now InSysBio presents public beta release of fIVE Calculator which is a web application designed to automatically calculate kinetic parameters from in vitro experiments for modeling of biosystems.

Dec 7, 2023, 08:06 AM by